James R Bridgeman, APRN - Medicare Nurse Practitioner in Batesville, AR

James R Bridgeman, APRN is a medicare enrolled "Nurse Practitioner - Family" in Batesville, Arkansas. He graduated from nursing school in 2019 and has 5 years of diverse experience with area of expertise as Nurse Practitioner. He is a member of the group practice White River Health System Inc and his current practice location is 1710 Harrison St, Batesville, Arkansas. You can reach out to his office (for appointments etc.) via phone at (870) 262-1200.

James R Bridgeman is licensed to practice in Arkansas (license number 122101) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1396394060.

Contact Information

James R Bridgeman, APRN
1710 Harrison St,
Batesville, AR 72501-7303
(870) 262-1200
Not Available



Provider's Profile

Full NameJames R Bridgeman
GenderMale
SpecialityNurse Practitioner
Experience5 Years
Location1710 Harrison St, Batesville, Arkansas
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • James R Bridgeman graduated from nursing school in 2019
  NPI Data:
  • NPI Number: 1396394060
  • Provider Enumeration Date: 09/05/2019
  • Last Update Date: 09/05/2019
  Medicare PECOS Information:
  • PECOS PAC ID: 9739410473
  • Enrollment ID: I20191011000473

Medical Identifiers

Medical identifiers for James R Bridgeman such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1396394060NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
363LF0000XNurse Practitioner - Family 122101 (Arkansas)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
White River Medical CenterBatesville, ARHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
White River Health System Inc0143134270150

News Archive

New immunotherapy treatment may offer hope for many pancreatic cancer patients

A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.

Effective vaccine booster schedules needed to fight against whooping cough resurgence

A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.

Newron Pharmaceuticals submits safinamide NDA to FDA

Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).

Scientists to test if chocolate cuts diabetes heart disease risk in women

Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. James R Bridgeman allows following entities to bill medicare on his behalf.
Entity NameWhite River Health System Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1568442127
PECOS PAC ID: 0143134270
Enrollment ID: O20060221000012

News Archive

New immunotherapy treatment may offer hope for many pancreatic cancer patients

A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.

Effective vaccine booster schedules needed to fight against whooping cough resurgence

A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.

Newron Pharmaceuticals submits safinamide NDA to FDA

Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).

Scientists to test if chocolate cuts diabetes heart disease risk in women

Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.

Read more Medical News

› Verified 8 days ago

Entity NameWhite River Health System Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1457396616
PECOS PAC ID: 0143134270
Enrollment ID: O20060830000031

News Archive

New immunotherapy treatment may offer hope for many pancreatic cancer patients

A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.

Effective vaccine booster schedules needed to fight against whooping cough resurgence

A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.

Newron Pharmaceuticals submits safinamide NDA to FDA

Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).

Scientists to test if chocolate cuts diabetes heart disease risk in women

Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.

Read more Medical News

› Verified 8 days ago

Entity NameWhite River Health System Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1871609743
PECOS PAC ID: 0143134270
Enrollment ID: O20070223000663

News Archive

New immunotherapy treatment may offer hope for many pancreatic cancer patients

A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.

Effective vaccine booster schedules needed to fight against whooping cough resurgence

A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.

Newron Pharmaceuticals submits safinamide NDA to FDA

Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).

Scientists to test if chocolate cuts diabetes heart disease risk in women

Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.

Read more Medical News

› Verified 8 days ago

Entity NameWhite River Health System Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1467519249
PECOS PAC ID: 0143134270
Enrollment ID: O20070503000423

News Archive

New immunotherapy treatment may offer hope for many pancreatic cancer patients

A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.

Effective vaccine booster schedules needed to fight against whooping cough resurgence

A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.

Newron Pharmaceuticals submits safinamide NDA to FDA

Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).

Scientists to test if chocolate cuts diabetes heart disease risk in women

Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.

Read more Medical News

› Verified 8 days ago

Entity NameWhite River Health System Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1477523348
PECOS PAC ID: 0143134270
Enrollment ID: O20110510000339

News Archive

New immunotherapy treatment may offer hope for many pancreatic cancer patients

A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.

Effective vaccine booster schedules needed to fight against whooping cough resurgence

A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.

Newron Pharmaceuticals submits safinamide NDA to FDA

Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).

Scientists to test if chocolate cuts diabetes heart disease risk in women

Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.

Read more Medical News

› Verified 8 days ago

Entity NameWhite River Health System Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1962482430
PECOS PAC ID: 0143134270
Enrollment ID: O20110614000786

News Archive

New immunotherapy treatment may offer hope for many pancreatic cancer patients

A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.

Effective vaccine booster schedules needed to fight against whooping cough resurgence

A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.

Newron Pharmaceuticals submits safinamide NDA to FDA

Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).

Scientists to test if chocolate cuts diabetes heart disease risk in women

Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.

Read more Medical News

› Verified 8 days ago

Entity NameWhite River Health System Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1760452643
PECOS PAC ID: 0143134270
Enrollment ID: O20111003000187

News Archive

New immunotherapy treatment may offer hope for many pancreatic cancer patients

A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.

Effective vaccine booster schedules needed to fight against whooping cough resurgence

A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.

Newron Pharmaceuticals submits safinamide NDA to FDA

Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).

Scientists to test if chocolate cuts diabetes heart disease risk in women

Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.

Read more Medical News

› Verified 8 days ago

Entity NameWhite River Health System Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1578543070
PECOS PAC ID: 0143134270
Enrollment ID: O20120725000268

News Archive

New immunotherapy treatment may offer hope for many pancreatic cancer patients

A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.

Effective vaccine booster schedules needed to fight against whooping cough resurgence

A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.

Newron Pharmaceuticals submits safinamide NDA to FDA

Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).

Scientists to test if chocolate cuts diabetes heart disease risk in women

Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.

Read more Medical News

› Verified 8 days ago

Entity NameWhite River Health System Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1962878207
PECOS PAC ID: 0143134270
Enrollment ID: O20160318001395

News Archive

New immunotherapy treatment may offer hope for many pancreatic cancer patients

A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.

Effective vaccine booster schedules needed to fight against whooping cough resurgence

A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.

Newron Pharmaceuticals submits safinamide NDA to FDA

Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).

Scientists to test if chocolate cuts diabetes heart disease risk in women

Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.

Read more Medical News

› Verified 8 days ago

Entity NameWhite River Health System Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1104275486
PECOS PAC ID: 0143134270
Enrollment ID: O20170119000552

News Archive

New immunotherapy treatment may offer hope for many pancreatic cancer patients

A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.

Effective vaccine booster schedules needed to fight against whooping cough resurgence

A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.

Newron Pharmaceuticals submits safinamide NDA to FDA

Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).

Scientists to test if chocolate cuts diabetes heart disease risk in women

Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.

Read more Medical News

› Verified 8 days ago

Entity NameWhite River Health System Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1013451186
PECOS PAC ID: 0143134270
Enrollment ID: O20170125002953

News Archive

New immunotherapy treatment may offer hope for many pancreatic cancer patients

A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.

Effective vaccine booster schedules needed to fight against whooping cough resurgence

A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.

Newron Pharmaceuticals submits safinamide NDA to FDA

Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).

Scientists to test if chocolate cuts diabetes heart disease risk in women

Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.

Read more Medical News

› Verified 8 days ago

Entity NameWhite River Health System Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1154770436
PECOS PAC ID: 0143134270
Enrollment ID: O20170216001323

News Archive

New immunotherapy treatment may offer hope for many pancreatic cancer patients

A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.

Effective vaccine booster schedules needed to fight against whooping cough resurgence

A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.

Newron Pharmaceuticals submits safinamide NDA to FDA

Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).

Scientists to test if chocolate cuts diabetes heart disease risk in women

Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. James R Bridgeman is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
James R Bridgeman, APRN
Po Box 42,
Thida, AR 72165-0042

Ph: (870) 612-0806
James R Bridgeman, APRN
1710 Harrison St,
Batesville, AR 72501-7303

Ph: (870) 262-1200

News Archive

New immunotherapy treatment may offer hope for many pancreatic cancer patients

A new immunotherapy treatment has shown dramatic results in treating advanced pancreatic cancer, a deadly cancer that has seen little progress in treatment over the last 20 years.

Effective vaccine booster schedules needed to fight against whooping cough resurgence

A key to victory in battle, according to Chinese general and military strategist Sun Tzu, is to know your enemy. In the current fight against whooping cough resurgence, perhaps the biggest obstacle is an incomplete understanding of its underlying causes, according to a University of Michigan population ecologist.

Newron Pharmaceuticals submits safinamide NDA to FDA

Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).

Scientists to test if chocolate cuts diabetes heart disease risk in women

Scientists in Britain are calling for volunteers to test whether chocolate can reduce the risk of heart disease in women with diabetes.

Read more News

› Verified 8 days ago


Nurse Practitioner Nurses in Batesville, AR

Mr. Leroy Maupin Jr., APRN
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 407 Virginia Dr, Batesville, AR 72501
Phone: 870-793-4200    Fax: 870-698-1353
Angela Burleson, MS, APRN
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 1215 Sidney St Ste 202, Batesville, AR 72501
Phone: 870-262-2000    
Rachel Jeannette Johnson,
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 905 20th St Ste B, Batesville, AR 72501
Phone: 870-569-4942    Fax: 870-569-4943
Mrs. Michelle Lee Hagen, ACNP-BC
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 1710 Harrison St, Batesville, AR 72501
Phone: 870-262-1200    Fax: 870-262-6199
Cynthia Elaine Jackson, APN
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 3443 Harrison St, Batesville, AR 72501
Phone: 870-698-1635    Fax: 870-612-3389
Brandy M Moore, APRN
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 255 Virginia Dr, Batesville, AR 72501
Phone: 870-793-4300    
Robin Kerr, APN
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 1215 Sidney St Ste 300, Batesville, AR 72501
Phone: 870-793-1126    Fax: 870-793-1180

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.